Rainmed Medical Limited (HKG:2297)

Rainmed Medical Statistics

Total Valuation

Rainmed Medical has a market cap or net worth of HKD 316.71 million. The enterprise value is 174.42 million.

Market Cap	316.71M
Enterprise Value	174.42M

Important Dates

The next estimated earnings date is Thursday, June 4, 2026.

Earnings Date	Jun 4, 2026
Ex-Dividend Date	n/a

Share Statistics

Rainmed Medical has 1.40 billion shares outstanding. The number of shares has increased by 10.63% in one year.

Current Share Class	1.40B
Shares Outstanding	1.40B
Shares Change (YoY)	+10.63%
Shares Change (QoQ)	+18.84%
Owned by Insiders (%)	47.85%
Owned by Institutions (%)	8.28%
Float	513.38M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	14.84
PB Ratio	0.80
P/TBV Ratio	0.81
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-2.03
EV / Sales	8.17
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-1.92

Financial Position

The company has a current ratio of 1.13, with a Debt / Equity ratio of 0.07.

Current Ratio	1.13
Quick Ratio	1.06
Debt / Equity	0.07
Debt / EBITDA	n/a
Debt / FCF	-0.30
Interest Coverage	-103.97

Financial Efficiency

Return on equity (ROE) is -20.68% and return on invested capital (ROIC) is -11.44%.

Return on Equity (ROE)	-20.68%
Return on Assets (ROA)	-9.28%
Return on Invested Capital (ROIC)	-11.44%
Return on Capital Employed (ROCE)	-20.66%
Weighted Average Cost of Capital (WACC)	7.14%
Revenue Per Employee	101,615
Profits Per Employee	-408,470
Employee Count	214
Asset Turnover	0.04
Inventory Turnover	0.91

Taxes

Income Tax	-41,174
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +18.95% in the last 52 weeks. The beta is 0.60, so Rainmed Medical's price volatility has been lower than the market average.

Beta (5Y)	0.60
52-Week Price Change	+18.95%
50-Day Moving Average	0.26
200-Day Moving Average	0.29
Relative Strength Index (RSI)	42.33
Average Volume (20 Days)	296,350

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Rainmed Medical had revenue of HKD 21.34 million and -85.78 million in losses. Loss per share was -0.07.

Revenue	21.34M
Gross Profit	10.06M
Operating Income	-83.30M
Pretax Income	-88.40M
Net Income	-85.78M
EBITDA	-74.99M
EBIT	-83.30M
Loss Per Share	-0.07

Balance Sheet

The company has 170.57 million in cash and 27.62 million in debt, with a net cash position of 142.95 million or 0.10 per share.

Cash & Cash Equivalents	170.57M
Total Debt	27.62M
Net Cash	142.95M
Net Cash Per Share	0.10
Equity (Book Value)	398.37M
Book Value Per Share	0.28
Working Capital	26.58M

Cash Flow

In the last 12 months, operating cash flow was -86.92 million and capital expenditures -3.76 million, giving a free cash flow of -90.68 million.

Operating Cash Flow	-86.92M
Capital Expenditures	-3.76M
Depreciation & Amortization	8.65M
Net Borrowing	-1.81M
Free Cash Flow	-90.68M
FCF Per Share	-0.06

Margins

Gross Margin	47.14%
Operating Margin	-390.38%
Pretax Margin	-414.28%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Rainmed Medical does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-10.63%
Shareholder Yield	-10.63%
Earnings Yield	-27.08%
FCF Yield	-28.63%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Rainmed Medical has an Altman Z-Score of -5.91 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-5.91
Piotroski F-Score	1